A Clinical Trial to Evaluate the Bone Metabolism and the Blood Sugar of Evogliptin and Dapagliflozin

NCT04706637 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Bone Diseases, Metabolic
Diabetes Mellitus, Type 2

Interventions

DRUG: Evogliptin
DRUG: Dapagliflozin

Sponsor

Kyung Hee University Hospital at Gangdong

Collaborators

[object Object]